Yu et al. [117], Change et al. [118, 119] prove the link between “ERBB2 and ERBB4 signaling pathways” and the endometrial cancer, while [120] reviews the role of “Rho GTPases signaling” in cancer. This evidence concerns the gene ERBB4 and endometrial cancer.